Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Cellular & Molecular Immunology
|
August 8, 2017
Interferons command Trim22 to fight against viruses
Qiaoshi Lian, Bing Sun
FEBS Letters
|
April 25, 2015
TRIM35 negatively regulates TLR7- and TLR9-mediated type I interferon production by targeting IRF7
Yanming Wang, Shanshan Yan, Bo Yang, et al.
European Journal of Immunology
|
February 6, 2014
Differential IL-10 production by DCs determines the distinct adjuvant effects of LPS and PTX in EAE induction
Haiyan Zhou, Yanming Wang, Qiaoshi Lian, et al.
Cell Research
|
April 15, 2017
Chemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation
Qiaoshi Lian, Jun Xu, Shanshan Yan, et al.
Plos Pathogens
|
June 27, 2015
TRIM30α Is a Negative-Feedback Regulator of the Intracellular DNA and DNA Virus-Triggered Response by Targeting STING
Yanming Wang, Qiaoshi Lian, Bo Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 8, 2019
Correction: Deficiency of the AIM2-ASC Signal Uncovers the STING-Driven Overreactive Response of Type I IFN and Reciprocal Depression of Protective IFN-γ Immunity in Mycobacterial Infection
Shanshan Yan, Hongbo Shen, Qiaoshi Lian, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 20, 2017
Deficiency of the AIM2-ASC Signal Uncovers the STING-Driven Overreactive Response of Type I IFN and Reciprocal Depression of Protective IFN-γ Immunity in Mycobacterial Infection
Shanshan Yan, Hongbo Shen, Qiaoshi Lian, et al.
Cellular & Molecular Immunology
|
February 26, 2020
TRIM34 attenuates colon inflammation and tumorigenesis by sustaining barrier integrity
Qiaoshi Lian, Shanshan Yan, Qi Yin, et al.
Science (New York, N.Y.)
|
June 18, 2026
CD4<sup>+</sup> T cells impair tumor growth through IL-3 and TNF-dependent vascular damage
Qiaoshi Lian, Jia Nie, Jatinder Singh, et al.
Immunity
|
April 3, 2026
Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironment
Vivien I Maltez, Charu Arora, Kyle P Gribbin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Cellular & Molecular Immunology
|
August 8, 2017
Interferons command Trim22 to fight against viruses
Qiaoshi Lian, Bing Sun
FEBS Letters
|
April 25, 2015
TRIM35 negatively regulates TLR7- and TLR9-mediated type I interferon production by targeting IRF7
Yanming Wang, Shanshan Yan, Bo Yang, et al.
European Journal of Immunology
|
February 6, 2014
Differential IL-10 production by DCs determines the distinct adjuvant effects of LPS and PTX in EAE induction
Haiyan Zhou, Yanming Wang, Qiaoshi Lian, et al.
Cell Research
|
April 15, 2017
Chemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation
Qiaoshi Lian, Jun Xu, Shanshan Yan, et al.
Plos Pathogens
|
June 27, 2015
TRIM30α Is a Negative-Feedback Regulator of the Intracellular DNA and DNA Virus-Triggered Response by Targeting STING
Yanming Wang, Qiaoshi Lian, Bo Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 8, 2019
Correction: Deficiency of the AIM2-ASC Signal Uncovers the STING-Driven Overreactive Response of Type I IFN and Reciprocal Depression of Protective IFN-γ Immunity in Mycobacterial Infection
Shanshan Yan, Hongbo Shen, Qiaoshi Lian, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 20, 2017
Deficiency of the AIM2-ASC Signal Uncovers the STING-Driven Overreactive Response of Type I IFN and Reciprocal Depression of Protective IFN-γ Immunity in Mycobacterial Infection
Shanshan Yan, Hongbo Shen, Qiaoshi Lian, et al.
Cellular & Molecular Immunology
|
February 26, 2020
TRIM34 attenuates colon inflammation and tumorigenesis by sustaining barrier integrity
Qiaoshi Lian, Shanshan Yan, Qi Yin, et al.
Science (New York, N.Y.)
|
June 18, 2026
CD4<sup>+</sup> T cells impair tumor growth through IL-3 and TNF-dependent vascular damage
Qiaoshi Lian, Jia Nie, Jatinder Singh, et al.
Immunity
|
April 3, 2026
Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironment
Vivien I Maltez, Charu Arora, Kyle P Gribbin, et al.
Page
of 2